New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer

by Henry Ford HealthA ViewRay MRIdian system at Henry Ford Health. Credit: Henry Ford HealthFindings from a recent prospective study show promising safety and patient outcomes data for locally advance
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome

by Nationwide Children's HospitalGraphical abstract. Credit:NAR Cancer(2023). DOI: 10.1093/narcan/zcad028In a paper published inNAR Cancer, researchers from the Center for C
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
A potentially novel approach to improving the efficacy of natural killer cell therapies

A potentially novel approach to improving the efficacy of natural killer cell therapies

by Ludwig Cancer ResearchGraphical abstract. Credit:Cell(2022). DOI: 10.1016/j.cell.2022.03.030Natural killer (NK) cells have lately become a hot focus of efforts to develop new immun
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
Dangers of late cervical cancer diagnosis in women of color

Dangers of late cervical cancer diagnosis in women of color

by Alex Osiadacz,Mayo ClinicCredit: Mayo Clinic News NetworkIn the past decade, nearly one-third of cervical cancer cases in the U.S. resulted in death according to the Centers for Disease Contr
Oncology January 30,2024
A DNA protein may be responsible for causing cancerous 'stress balls' in the body

A DNA protein may be responsible for causing cancerous 'stress balls' in the body

by Brooke Kleiboer,University of SaskatchewanCredit: Pixabay/CC0 Public DomainIn 2022, an estimated 7,000 Canadians were diagnosed with leukemia, a term used to define cancer of the blood cells.
Oncology January 30,2024
A DNA protein may be responsible for causing cancerous 'stress balls' in the body

A DNA protein may be responsible for causing cancerous 'stress balls' in the body

by Brooke Kleiboer,University of SaskatchewanCredit: Pixabay/CC0 Public DomainIn 2022, an estimated 7,000 Canadians were diagnosed with leukemia, a term used to define cancer of the blood cells.
Oncology January 30,2024
Study shows a new approach to target a deadly form of prostate cancer

Study shows a new approach to target a deadly form of prostate cancer

by University of MichiganGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.167440A study from the University of Michigan Rogel Cancer Center uncovers a new mechan
Oncology January 30,2024
Study shows a new approach to target a deadly form of prostate cancer

Study shows a new approach to target a deadly form of prostate cancer

by University of MichiganGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.167440A study from the University of Michigan Rogel Cancer Center uncovers a new mechan
Oncology January 30,2024
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone
Oncology January 30,2024
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers

by Johns Hopkins University School of MedicineJ1568 study treatment schema.Eligible patients with clinically resectable PDA received the first priming study treatment Cy-GVAX-based therapy (alone
Oncology January 30,2024
Researchers reveal why obesity makes ovarian cancer more deadly

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho
Oncology January 30,2024
Researchers reveal why obesity makes ovarian cancer more deadly

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho
Oncology January 30,2024
Discovery of a gene that could be key for reducing breast cancer risk

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu
Oncology January 30,2024
Discovery of a gene that could be key for reducing breast cancer risk

Discovery of a gene that could be key for reducing breast cancer risk

by University of OtagoCharacterization of SULT1A1. a Genomic viewer (UCSC) of the SULT1A1 gene locus with copy number variants; deletion (red) and duplication (blue). b Dosage effect in breast tu
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com